84 related articles for article (PubMed ID: 12854942)
1. Olanzapine for intractable nausea in palliative care patients.
Jackson WC; Tavernier L
J Palliat Med; 2003 Apr; 6(2):251-5. PubMed ID: 12854942
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.
Srivastava M; Brito-Dellan N; Davis MP; Leach M; Lagman R
J Pain Symptom Manage; 2003 Jun; 25(6):578-82. PubMed ID: 12782438
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine in the Management of Difficult to Control Nausea and Vomiting in a Palliative Care Population: A Case Series.
MacKintosh D
J Palliat Med; 2016 Jan; 19(1):87-90. PubMed ID: 26398872
[TBL] [Abstract][Full Text] [Related]
4. A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain.
Passik SD; Lundberg J; Kirsh KL; Theobald D; Donaghy K; Holtsclaw E; Cooper M; Dugan W
J Pain Symptom Manage; 2002 Jun; 23(6):526-32. PubMed ID: 12067777
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine for intractable nausea and vomiting in palliative care patients not receiving chemotherapy.
Atkinson SR
J Palliat Med; 2014 May; 17(5):503-4. PubMed ID: 24708452
[No Abstract] [Full Text] [Related]
6. Re: Olanzapine-induced delirium.
Prommer E
J Pain Symptom Manage; 2005 Feb; 29(2):119-20. PubMed ID: 15733804
[No Abstract] [Full Text] [Related]
7. Use of olanzapine for the relief of nausea and vomiting in patients with advanced cancer: a multicenter survey in Japan.
Kaneishi K; Nishimura K; Sakurai N; Imai K; Matsuo N; Takahashi N; Okamoto K; Suga A; Sano H; Maeda I; Nishina H; Yamaguchi T; Morita T; Iwase S
Support Care Cancer; 2016 Jun; 24(6):2393-5. PubMed ID: 26838020
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine-induced delirium in a terminally ill cancer patient.
Morita T; Tei Y; Shishido H; Inoue S
J Pain Symptom Manage; 2004 Aug; 28(2):102-3. PubMed ID: 15276190
[No Abstract] [Full Text] [Related]
9. Re: "Olanzapine for Nonchemotherapy Related Nausea and Emesis in Patients With a Palliative Care Consult".
Lowry MF
J Pain Symptom Manage; 2024 Jan; 67(1):e113. PubMed ID: 37611880
[No Abstract] [Full Text] [Related]
10. Remission of chemotherapy-induced emesis with concurrent olanzapine treatment: a case report.
Pirl WF; Roth AJ
Psychooncology; 2000; 9(1):84-7. PubMed ID: 10668063
[No Abstract] [Full Text] [Related]
11. Management of nausea and vomiting in palliative care.
Neoh K; Adkinson L; Montgomery V; Hurlow A
Br J Hosp Med (Lond); 2014 Jul; 75(7):391-2, 394-6. PubMed ID: 25040518
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine for Nausea, Delirium, Anxiety, Insomnia, and Cachexia #315.
Felton M; Weinberg R; Pruskowski J
J Palliat Med; 2016 Nov; 19(11):1224-1225. PubMed ID: 27267313
[No Abstract] [Full Text] [Related]
13. The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature.
Saudemont G; Prod'Homme C; Da Silva A; Villet S; Reich M; Penel N; Gamblin V
BMC Palliat Care; 2020 Apr; 19(1):56. PubMed ID: 32321488
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine versus divalproex in the treatment of acute mania.
Tohen M; Baker RW; Altshuler LL; Zarate CA; Suppes T; Ketter TA; Milton DR; Risser R; Gilmore JA; Breier A; Tollefson GA
Am J Psychiatry; 2002 Jun; 159(6):1011-7. PubMed ID: 12042191
[TBL] [Abstract][Full Text] [Related]
15. Six-month outcomes for patients who switched to olanzapine treatment.
Noordsy DL; O'Keefe C; Mueser KT; Xie H
Psychiatr Serv; 2001 Apr; 52(4):501-7. PubMed ID: 11274497
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
[TBL] [Abstract][Full Text] [Related]
17. Palliative care. Nausea and vomiting.
Kinghorn S
Nurs Times; 1997 Aug 13-19; 93(33):57-60. PubMed ID: 9335885
[No Abstract] [Full Text] [Related]
18. Intractable nausea and vomiting successfully related with granisetron 5-hydroxytryptamine type 3 receptor antagonists in Palliative Medicine.
Buchanan D; Muirhead K
Palliat Med; 2007 Dec; 21(8):725-6. PubMed ID: 18073263
[No Abstract] [Full Text] [Related]
19. Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy.
Stuart-Harris RC; Mooney CA; Smith IE
Clin Oncol; 1983 Jun; 9(2):143-6. PubMed ID: 6309451
[TBL] [Abstract][Full Text] [Related]
20. Marked improvement of Meige's syndrome with olanzapine in a schizophrenic patient.
Fukui H; Murai T
J Neuropsychiatry Clin Neurosci; 2002; 14(3):355-6. PubMed ID: 12154163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
